Communicating about chronic pain

For Australians with a disability or those older citizens with Alzheimer’s Disease or Dementia, communicating chronic pain has been a significant challenge – but now technology has the answer.

Painchek® has a clinically-validated and government-backed mobile app which uses artificial intelligence to assess the micro-facial features of pain in a person’s face and to identify the presence and severity of pain.

In 2019, the Federal Government announced a national trial of Painchek® whereby aged care providers could sign up to a fully funded trial until 31 May 2021. 

As the aged care trial draws to an end, the Federal Government’s substantive investment in aged care announced in the 2021-2022 Federal Budget should unlock ongoing investment in technology solutions to assist those in need.

During the trial more than 350,000 Painchek® assessments were conducted, but that’s just the tip of the iceberg when it comes to need – with one in four Australians with a disability experiencing severe and chronic pain.

H/Advisors APA continues to be engaged to raise the profile of the challenge of communicating pain and the Painchek® solution – to form a compelling narrative and tell the story through mainstream media and with government.